SEDABARB

This brand name is authorized in South Africa

Active ingredients

The drug SEDABARB contains one active pharmaceutical ingredient (API):

1 Phenobarbital
UNII YQE403BP4D - PHENOBARBITAL

Phenobarbital has sedative effects and has some protective action against all varieties of human partial and generalised epilepsy, with the exception of absence seizures. Phenobarbital is also effective in preventing seizures in the corresponding experimental animal models of epilepsy.

Read about Phenobarbital

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SEDABARB Tablet Health Products Regulatory Authority (ZA) MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N03AA02 Phenobarbital N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AA Barbiturates and derivatives
Discover more medicines within N03AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ZA Health Products Regulatory Authority Identifier(s): E/2.3/107

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.